IRCT20080728001031N35
Completed
Phase 1
Safety of intradiscal injection of nucleus pulposus derived stromal cells in regeneration of human degenerated lumbar disc in patients with chronic low back pain
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Royan Institute
- Enrollment
- 5
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 18 and 65 years
- •Of both sexes
- •Degenerative intervertebral disc in one or two lumbar intervertebral discs with pain that has not responded to previous supportive therapies, including the use of conventional analgesics or physiotherapy within the last 6 months.
- •The fibrous ring is able to hold the injected cell based on the discography performed. This means that stage of the disease must be 2,3 or 4 and stage 5 cannot be included in the study.
- •Reduction of intervertebral disc height by 50% or more based on radiography.
- •Do not have a vertebral infection.
- •Have no uncontrolled chronic underlying disease that is prohibited for treatment.
- •Have no uncontrolled chronic underlying disease that is prohibited for treatment.
- •Do not be pregnant or breastfeeding women.
- •Not positive and transmissible viral infection.
Exclusion Criteria
- •infection signs or positive serology for HIV, hepatitis and syphilis
- •allergy to gentanicin, or to bovine, cattle or horse serum
- •congenital or acquired disease leading to spine deformities that may upset cell application
- •spinal segmental instability, spinal canal stenos, isthmus pathology, and other conditions that may compromise the study
- •modic 3 changes on MRI images
- •overweight with body mass index greater than 30\.5
- •immunosuppression
- •participation in another clinical trial or treatment with another investigational product within 30 days prior to inclusion in the study
- •other conditions that may, according to medical criteria, discourage participation in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Safety of intra-discal transplantation of allogeneic clonal bone marrow derived mesenchymal stromal cells in patients with low back pain induced by degenerative disc diseasechronic discogenic low back pain.Intervertebral disc disorders with radiculopathy, lumbar regionM51.16IRCT20080728001031N30ATI tech pharmed5
Active, not recruiting
Phase 1
Corticosteroids and discopathieschronic low back painTherapeutic area: Body processes [G] - Physical Phenomena [G01]EUCTR2011-005488-25-FRH Montpellier40
Completed
Phase 1
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Disc DegenerationDegenerative Disc DiseaseNCT03955315DiscGenics, Inc.38
Completed
Phase 1
K cell therapy in pediatrics with brain gliomaIRCT20170122032121N6Royan institute10
Recruiting
Phase 2
Effect of Injection of Fat Stem Cells in Treatment of Lumbar DisordersChronic discogenic low back pain.Other intervertebral disc degeneration, lumbar regionM51.36IRCT20131124015515N4Shahid Beheshti University of Medical Sciences10